AUTHOR=Fang Gang , Pi Zhipeng , An Yiping , Cao Xinxin , Li Wei , Zhu Xiangjun , Ding Jinxi 

TITLE=Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned survival model

JOURNAL=Frontiers in Pharmacology

VOLUME=16

YEAR=2025

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1400422

DOI=10.3389/fphar.2025.1400422

ISSN=1663-9812